Stroke Clinical Trials 2024

Stroke Clinical Trials 2024

Stroke research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in stroke clinical trials today.

Stroke Clinical Trials

Here are the 6 most popular medical studies for stroke

Popular filter options for stroke trials

Hemorrhagic Stroke Clinical Trials

View 96 Hemorrhagic Stroke medical studies.

Ischemic Stroke Clinical Trials

View 95 Ischemic Stroke medical studies.

Stroke Clinical Trials With No Placebo

View 99 stroke medical studies that do not have a placebo group.

View More Stroke Trials

See another 84 medical studies focused on stroke.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to stroke

What are the top hospitals conducting stroke research?

In the quest to combat stroke, several top hospitals across the United States are leading the way in clinical trials. One such institution is the Shirley Ryan AbilityLab located in Chicago, which currently has six active stroke trials and a commendable history of 34 completed trials dedicated specifically to this condition. Having conducted their first stroke trial in 2015, this forward-thinking facility is at the forefront of innovative research. Meanwhile, on the southeastern coast lies another notable contender - the Medical University of South carolina in Charleston. With five ongoing stroke trials and an impressive track record of 56 previous studies since their inaugural trial in 2003, they have firmly established themselves as pioneers within the field.

On America's west coast, Cedars-Sinai Medical Center situated in Los Angeles also plays a significant role. While conducting four active stroke trials presently and having completed a total of 14 experiments over time after starting their first investigation backin2003.With its rich medical history and reputation for excellence, Massachusetts General Hospital (located) Boston likewise contributes significantly with four ongoing clinical tests related to strokes while having accomplished forty-eight prior inquiries subsequent from initiating them initially around1997.Lastly possessing equal merit comes Henry Ford Hospital based out Detroit where there are around four current living trial cases alongside nineteen previously held ones; theirs can be traced dating back only fifteen years ago towards initiation on-stroke testing specifically started during year2005.

The dedication displayed by these prestigious institutions highlights not just their commitment but also serves as hope for patients affected by strokes both now and in future times ahead.Their tireless efforts bring us closer to breakthroughs that could ultimately transform treatments for this debilitating condition affecting individuals nationwide

Which are the best cities for stroke clinical trials?

When it comes to stroke clinical trials, several cities offer opportunities for cutting-edge research and advancement in care. New york City stands out with 17 active trials studying treatments like the Amulet Left Atrial Appendage Occluder, WATCHMAN FLX LAAC Device, and CPAP. Chicago also plays a significant role with its 17 ongoing studies focusing on interventions such as CPAP and the Amulet Left Atrial Appendage Occluder. In Baltimore, Maryland, researchers are conducting 15 trials exploring various approaches including Output-Focus Condition and antiplatelet therapy. Cleveland, Ohio joins the ranks with 15 active trials investigating treatments like CPAP and implantation methods. Lastly, Los Angeles offers 14 ongoing studies examining interventions such as CPAP and antiplatelet therapy. These cities provide individuals affected by stroke access to promising clinical trials that contribute to advancements in treatment options and improved outcomes.

Which are the top treatments for stroke being explored in clinical trials?

Exciting developments in stroke treatment are occurring through ongoing clinical trials. The mGain system shows great potential, currently being explored in one active trial and marking the beginning of stroke research in 2023. Another promising avenue is intervention, with one active trial and a total of eight historical studies since its introduction in 2005. Additionally, split-belt treadmill training offers new possibilities, being investigated in one active trial after its first listing in 2021. Finally, the innovative Neurosleeve introduces a fresh approach to stroke management with ongoing research happening within a single trial since its inception year of 2020. These groundbreaking treatments hold promise for advancing stroke care and improving patient outcomes.

What are the most recent clinical trials for stroke?

Recent clinical trials have brought new hope for stroke patients, with several promising treatments on the horizon. One notable trial examined the effectiveness of evolocumab in combination with routine lipid management for stroke prevention. Another study explored the potential benefits of maraviroc as a treatment option for individuals who have experienced a stroke. Additionally, researchers investigated the use of an innovative rehabilitation robot called In Motion to aid in post-stroke recovery. The efficacy of methylphenidate and oral anticoagulants were also evaluated in separate trials aimed at improving outcomes for stroke patients. These ongoing studies represent significant advancements in our understanding and treatment of strokes, offering renewed possibilities for those affected by this devastating condition.

What stroke clinical trials were recently completed?

Recent advancements in stroke research have seen the completion of several pivotal clinical trials. In October 2021, Prolong Pharmaceuticals wrapped up a trial investigating the efficacy of PP-007 in stroke patients. Another significant milestone was reached in December 2020 when NoNO Inc. concluded their Nerinetide study, offering potential insights into new treatment options for this devastating condition. Additionally, the University of Cincinnati finalized their Nicardipine trial back in January 2020 and Bristol-Myers Squibb completed an Aspirin study in January 2019. These remarkable endeavors demonstrate the ongoing commitment to advancing stroke treatments and improving patient outcomes.